No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
AU Stock MarketDetailed Quotes
ARX Aroa Biosurgery Ltd
- 0.620
- +0.050+8.77%
20min DelayMarket Closed Jun 7 16:00 AET
213.41MMarket Cap-22142P/E (Static)
0.630High0.570Low533.44KVolume0.570Open0.570Pre Close319.87KTurnover0.99552wk High0.22%Turnover Ratio344.21MShares0.47552wk Low-0.028EPS TTM150.78MFloat Cap1.745Historical HighLossP/E (Static)243.19MShs Float0.475Historical Low-0.028EPS LYR10.53%Amplitude--Dividend TTM2.45P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Analysts Offer Insights on Healthcare Companies: Aroa Biosurgery Ltd (AU:ARX), Cassava Sciences (SAVA) and Amplifon S.p.A. (GB:0N61)
Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Full-Year Results
Aroa Biosurgery Price Target Cut 13% to A$1.05/Share by Morgans
Aroa Biosurgery Price Target Cut 13% to A$1.05/Share by Morgans
Aroa Biosurgery Ltd: FY24 Full Year Results Presentation
Aroa Biosurgery Ltd: FY24 Appendix 4E and Full Year Results
Aroa Biosurgery Cut to Overweight From Buy by Jarden >ARX.AU
Aroa Biosurgery Cut to Overweight From Buy by Jarden >ARX.AU
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg